In Rome, on February 25, 2025, the Cali Fund officially commenced its operations within the restored setting of the 16th Conference of the Parties to the Convention on Biological Diversity. The fund serves a specific and focused purpose: to transfer financial resources from corporations that utilize digital sequence information (DSI) on genetic resources, and redirect these funds towards the countries and communities that are the original sources of these genetic resources.
DSI refers to the raw genetic code of organisms, a digital entity rather than a physical specimen such as a plant leaf or blood sample. A Swiss pharmaceutical company, for instance, can obtain the genome of a medicinal plant from the Amazon, run computational simulations, and develop a drug without ever setting foot in Brazil. Under the current legal framework, the indigenous stewards of the plant, who have nurtured it for generations, see no compensation.
The Cali Fund aims to address this issue. Nestled within the Convention on Biological Diversity’s regulatory framework, the treaty has long advocated for fair and equitable benefit-sharing, but enforcement has been lax.
Companies could argue they were not utilizing the physical resource, only information about it. The Cali Fund addresses this loophole by taxing the information itself. This is not a voluntary initiative.
The fund will procure resources from private sector entities that utilize DSI. The announcement did not disclose the specific percentage or dollar amount companies will contribute.
This detail is crucial. If the fee is too low, the fund will serve merely as a symbol. If set high enough to matter, it will reshape the economics of bioprospecting.
The location of the launch was strategic. Rome is the base of the Food and Agriculture Organization, a UN body that has observed for decades as genetic resources from developing nations are patented and sold back at premium prices.
By hosting the launch during the 16th Conference of the Parties, a clear message was sent: this is not a peripheral event. It is a central function of the biodiversity treaty. Biodiverse countries have been lobbying for a mechanism like this since the treaty’s inception in 1992.
The delay was not technical. It was political.
Wealthy nations with robust biotech sectors resisted any obligation to pay for data. The Cali Fund signifies a breakthrough in this stalemate. It recognizes that data is not impartial. It has origins.
It has value. And this value should be shared.
Indigenous peoples and local communities are explicitly named in the fund’s design as intended beneficiaries. This is uncommon. Most international funds funnel money through governments.
The Cali Fund seems to bypass this level, at least theoretically. Whether the funds reach the community level depends on governance structures yet to be established.
The fund serves a conservation function, albeit indirectly. Funds can be used for park rangers, seed banks, and biodiversity mapping. However, the fund alone cannot halt deforestation.
The fund’s true power lies in its symbolism: it asserts that nature’s code is not free for the taking. This principle, once established, can be extended to other forms of biological data, synthetic biology, and the entire spectrum of bio-digital convergence.
The world is experiencing a rate of species extinction not seen since the age of the dinosaurs. The Cali Fund will not halt this alone. But it is one of the few financial instruments designed to remunerate the people who sustain ecosystems.
This shift in logic could, with the right details, become a reality.
Related Stories
Cali Fund Launches to Share DSI Genetic Profits Cali Fund
